<div id="readability-page-1"><div><p>As global markets grapple with concerns over AI valuations and economic uncertainties, the Asian market has not been immune to these challenges, experiencing fluctuations amid investor caution. In this climate, growth companies in Asia with high insider ownership are particularly intriguing as they often indicate strong internal confidence and alignment of interests between management and shareholders.</p><h3>Top 10 Growth Companies With High Insider Ownership In Asia</h3><table><tbody><tr><td><strong>Name</strong></td><td><strong>Insider Ownership</strong></td><td><strong>Earnings Growth</strong></td></tr><tr><td>UTI (KOSDAQ:A179900)</td><td>25.2%</td><td>110.4%</td></tr><tr><td>Streamax Technology (SZSE:002970)</td><td>32.5%</td><td>33.1%</td></tr><tr><td>Seers Technology (KOSDAQ:A458870)</td><td>33.9%</td><td>78.8%</td></tr><tr><td>Novoray (SHSE:688300)</td><td>23.6%</td><td>31.4%</td></tr><tr><td>Loadstar Capital K.K (TSE:3482)</td><td>31%</td><td>23.6%</td></tr><tr><td>Laopu Gold (SEHK:6181)</td><td>34.8%</td><td>34.3%</td></tr><tr><td>J&amp;V Energy Technology (TWSE:6869)</td><td>17.5%</td><td>31.6%</td></tr><tr><td>Gold Circuit Electronics (TWSE:2368)</td><td>31.4%</td><td>32.6%</td></tr><tr><td>Fulin Precision (SZSE:300432)</td><td>11.6%</td><td>55.2%</td></tr><tr><td>Bora Pharmaceuticals (TWSE:6472)</td><td>11.9%</td><td>20.3%</td></tr></tbody></table><p>Click here to see the full list of 637 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.</p><p>We'll examine a selection from our screener results.</p><h2>Beijing Sun-Novo Pharmaceutical Research (SHSE:688621)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> Beijing Sun-Novo Pharmaceutical Research Co., Ltd. is a contract research company focused on drug research and development in China, with a market cap of CN¥7.49 billion.</p><p><strong>Operations:</strong> Beijing Sun-Novo Pharmaceutical Research Co., Ltd. specializes in drug research and development as a contract research organization in China.</p><p><strong>Insider Ownership:</strong> 35.3%</p><p><strong>Revenue Growth Forecast:</strong> 21.7% p.a.</p><p>Beijing Sun-Novo Pharmaceutical Research shows strong growth potential, with earnings expected to increase by 33.02% annually, outpacing the Chinese market's 27.6%. Despite a decline in profit margins from 19.1% to 13.1%, revenue is forecasted to grow at a robust 21.7% per year, surpassing market averages. The company’s Return on Equity is projected to reach a high of 24.2%, while its P/E ratio of 56.3x remains below industry norms, suggesting relative value in the sector.</p><ul><li>Unlock comprehensive insights into our analysis of Beijing Sun-Novo Pharmaceutical Research stock in this growth report.</li><li>In light of our recent valuation report, it seems possible that Beijing Sun-Novo Pharmaceutical Research is trading beyond its estimated value.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38acfcf2-9e0e-4f05-a931-9de5d793c029/chart/ownership-breakdown"/><figcaption>SHSE:688621 Ownership Breakdown as at Nov 2025</figcaption></figure><h2>POCO Holding (SZSE:300811)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> POCO Holding Co., Ltd. specializes in developing, producing, and selling alloy soft magnetic powder and components for electronic equipment, with a market cap of CN¥22 billion.</p><p><strong>Operations:</strong> POCO Holding Co., Ltd. generates revenue from the development, production, and sale of alloy soft magnetic powder, alloy soft magnetic cores, and chip inductance components for electronic equipment users.</p><p><strong>Insider Ownership:</strong> 24%</p><p><strong>Revenue Growth Forecast:</strong> 24.8% p.a.</p><p>POCO Holding demonstrates strong growth prospects with earnings expected to grow at 29.7% annually, surpassing the Chinese market's 27.6%. Revenue is forecasted to increase by 24.8% per year, outpacing the market average of 14.4%. Despite a volatile share price recently, the company reported CNY 1.3 billion in revenue for the first nine months of 2025, up from CNY 1.23 billion last year, indicating steady progress in its financial performance.</p><ul><li>Get an in-depth perspective on POCO Holding's performance by reading our analyst estimates report here.</li><li>According our valuation report, there's an indication that POCO Holding's share price might be on the expensive side.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4831af70-abcd-4fa9-8fe8-43d190e41a33/chart/ownership-breakdown"/><figcaption>SZSE:300811 Ownership Breakdown as at Nov 2025</figcaption></figure><h2>Silergy (TWSE:6415)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Silergy Corp. designs, manufactures, and sells integrated circuit products and related technical services both in China and internationally, with a market cap of NT$79.12 billion.</p><p><strong>Operations:</strong> The company generates revenue primarily from its semiconductors segment, amounting to NT$18.53 billion.</p><p><strong>Insider Ownership:</strong> 14.2%</p><p><strong>Revenue Growth Forecast:</strong> 15.5% p.a.</p><p>Silergy's growth trajectory is robust, with earnings projected to rise 33.71% annually, outpacing the Taiwanese market's 20.2% forecast. Despite a slight dip in Q3 sales and net income compared to last year, nine-month figures show an increase in net income from TWD 1,391.25 million to TWD 1,668.88 million. Trading at a significant discount to its estimated fair value and lacking recent insider trading activity, Silergy remains an intriguing investment opportunity in Asia's growth sector.</p><ul><li>Click to explore a detailed breakdown of our findings in Silergy's earnings growth report.</li><li>Our valuation report here indicates Silergy may be undervalued.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/87e4e4ef-76b0-48c8-87b1-e4ec48c58796/chart/ownership-breakdown"/><figcaption>TWSE:6415 Ownership Breakdown as at Nov 2025</figcaption></figure><h2>Summing It All Up</h2><ul><li>Investigate our full lineup of 637 Fast Growing Asian Companies With High Insider Ownership right here.</li><li>Interested In Other Possibilities? Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.      It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.      All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p></div></div>

300432

06181

<p>The article highlights growth companies in Asia with high insider ownership, indicating strong internal confidence. Key companies include UTI, Streamax Technology, Seers Technology, Novoray, Loadstar Capital, Laopu Gold, J&V Energy Technology, Gold Circuit Electronics, Fulin Precision, and Bora Pharmaceuticals. Detailed analysis is provided for Beijing Sun-Novo Pharmaceutical Research, POCO Holding, and Silergy, showcasing their growth potential and financial performance. The article emphasizes the importance of insider ownership in aligning management and shareholder interests.</p>

3 Asian Growth Companies With High Insider Ownership To Watch